Last update:

Gastroenterology news

Stomach bacterium hijacks healing signals to drive precancerous changes, study finds

Stomach cancer is one of the deadliest forms of cancer. Unlike many other types of cancer, however, one of its main causes is well known: chronic infection with the bacterium Helicobacter pylori. A team headed by Charité—Universitätsmedizin ...

Experimental mRNA therapy dramatically extends treatment window for acetaminophen overdose in preclinical models

When a patient arrives at the hospital with an acetaminophen overdose, it's often a race against the clock. The only FDA-approved antidote for overdose-related liver injury, N‑acetylcysteine, must be administered within hours ...

Gut microbiome can reveal risk of type 2 diabetes

Changes in the composition of gut bacteria could provide an early warning of type 2 diabetes (T2D), according to new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) ...

Probiotics linked to fewer deaths in premature babies

Probiotic supplementation in very preterm babies was linked to a lower risk of both severe intestinal disease and death. This is shown by a new study from the Karolinska Institutet, published in JAMA Network Open. The findings ...

B cells may help predict risk of colitis from immunotherapy

Researchers at The University of Texas MD Anderson Cancer Center have identified a previously unknown role for B cells, adaptive immune cells, in triggering and sustaining colitis as a side effect of immune checkpoint inhibitors, ...

How culture, stress, and social life may shape gut health

Abdominal pain before an important exam, nausea during intense stress, or sudden intestinal problems following difficult life experiences—many people regard such symptoms as a temporary bodily reaction. However, a growing ...

Study on circulating tumor DNA shows clear benefits

After surgery for colon cancer, many patients face the question of whether follow-up chemotherapy is necessary to prevent a possible relapse. The decision is particularly difficult in so-called Stage II, the intermediate-risk ...